Impact of Chloroprocaine (CLOROTEKAL®) on Eligibility for Discharge From Hospital After Outpatient Surgery

NCT02152293 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 620

Last updated 2015-05-25

No results posted yet for this study

Summary

The purpose of this study is to assess, in real life, the efficacy and the eligibility for discharge of a local anesthetic, CLOROTEKAL®, used for spinal anesthesia in short outpatient surgery.

Conditions

  • Spinal Anesthesia
  • Outpatient Surgery

Sponsors & Collaborators

  • Nordic Pharma SAS

    lead INDUSTRY

Principal Investigators

  • Hélène HERMAN-DEMARS, MD · Nordic Pharma

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02152293 on ClinicalTrials.gov